Obesity is associated with increased morbidity and mortality from cardiovascular disease, diabetes and cancer. Although obesity is a multi-factorial heterogeneous condition, fat accumulation in visceral depots is most highly associated with these risks. Pathological glucocorticoid excess (i.e. in Cushing's syndrome) is a recognised, reversible cause of visceral fat accumulation. The aim of this study was to identify depot-specific glucocorticoid-target genes in adipocyte precursor cells (preadipocytes) using Affymetrix microarray technique. Confluent preadipocytes from subcutaneous (SC) and omental (OM) adipose tissue collected from five female patients were treated for 24 h with 100 nM cortisol (F), RNA was pooled and hybridised to the Affymetrix U133 microarray set. We identified 72 upregulated and 30 downregulated genes by F in SC cells. In OM preadipocytes, 56 genes were increased and 19 were decreased. Among the most interesting were transcription factors, markers of adipocyte differentiation and glucose metabolism, cell adhesion and growth arrest protein factors involved in G-coupled and Wnt signalling. The Affymetrix data have been confirmed by quantitative realtime PCR for ten specific genes, including HSD11B1, GR, C/EBPa, C/EBPb, IL-6, FABP4, APOD, IRS2, AGTR1 and GHR. One of the most upregulated genes in OM but not in SC cells was HSD11B1.
Introduction
The magnitude and severity of the obesity epidemic (Kopelman 2000) have provided the impetus to further understand its genetic basis as well as focussing attention on the neuroendocrine regulation of appetite control and energy expenditure and adipocyte cell biology. Crucially, fat distribution is of pivotal importance with central or visceral adiposity conferring the greatest risk of premature mortality (Jensen 1997) , and therefore, there is a need to define factors that regulate adipose distribution. Human adipose tissue exhibits different properties depending on their anatomical localisation, and has different sensitivity to glucocorticoids (Bujalska et al. 1997 , Fried et al. 1998 .
Clinical observations in patients with Cushing's syndrome who develop reversibly central obesity highlight the importance of glucocorticoids in this regard (Rebuffe-Scrive 1988) . Glucocorticoids (GCs) induce adipocyte differentiation (Hauner et al. 1987) preferentially within visceral adipose tissue due to increased glucocorticoid receptor (GR) expression (Bronnegard et al. 1990) , although other tissue-specific factors may be important.
In human adipose tissue, cortisol availability to bind and activate GR is controlled by 11b-hydroxysteroid dehydrogenase type-1 (11b-HSD1). 11b-HSD1 amplifies glucocorticoid action by reducing inactive cortisone (E) to active cortisol (F) (Lakshmi & Monder 1988) and is highly expressed in omental (OM) compared with subcutaneous (SC) fat. Furthermore in primary adipose cultures, 11b-HSD1 expression and activity are induced by F itself (Bujalska et al. 1997) , thus representing a novel mechanism whereby cells can generate F locally independent of circulating concentrations. Several factors are known to regulate 11b-HSD1 expression and activity in the liver (Jamieson et al. 1995) and adipocytes; the most potent inducers are glucocorticoids, cytokines (leptin, tumour necrosis factor (TNF)a, interleukin (IL)-1b, IL-4, IL-6 and IL-14; Handoko et al. 2000 , Tomlinson et al. 2001 and peroxisome proliferator activated receptor (PPARg) agonists (Berger et al. 2001 , Laplante et al. 2003 . Additionally, a significant role for C/EBP transcription factors in regulating rat hepatic 11b-HSD1 has been reported (Williams et al. 2000) . Amongst the factors suppressing 11b-HSD1 activity are: growth hormone, insulin-like growth factor-I (IGF-I) (Moore et al. 1999 , Tomlinson et al. 2001 , liver X receptors (Stulnig et al. 2002) , PPARa agonists (Hermanowski-Vosatka et al. 2000) and pituitary hormones like corticotrophin-releasing hormone and adrenocorticotrophin hormone (Friedberg et al. 2003) .
Microarray approaches have been increasingly used to study gene profiling during adipocyte differentiation; however, most of these studies were carried out on mouse cell lines and not on human primary preadipocyte cultures (Burton et al. 2002 , Jessen & Stevens 2002 , Wang et al. 2004 . On this background, we aimed to identify factors that might regulate 11b-HSD1 gene transcription in human OM versus SC adipose tissue. We have also hypothesised that the identification of GR-induced target genes in human OM versus SC adipose tissue will increase our knowledge base of the predilection of glucocorticoids to increase visceral fat mass and might reveal exciting candidate targets involved in the pathogenesis of central obesity.
Materials and methods
Human preadipocyte cell culture Paired SC and OM abdominal adipose tissue was obtained from five females (mean age 44 . 8 years, mean body mass index 29 . 4 kg/m 2 ; patient details shown in Table 1 ). All patients were undergoing hysterectomy and not on any hormonal treatment. Tissues were dispersed with collagenase 1 as described earlier (Bujalska et al. 1999) . Preadipocytes were seeded in Dulbecco's Modified Eagle's Medium/Ham's Nutrient Mixture F-12 (DMEM/F12) media with 10% FCS into six-well tissue culture dish and cultured to confluence for 4-6 days. Media were changed every other day. The study had the approval of the local research ethics committee, and all patients had given written informed consent prior to study inclusion.
Glucocorticoid treatment
Confluent SC and OM preadipocytes were treated with 100 nM F for 24 h in serum-free DMEM/F12 media. In control cells, F was omitted.
RNA isolation
Total RNA was extracted from primary cultures using TriReagent (Sigma). Total RNA was extracted from five confluent primary cultures of human SC and OM preadipocytes treated with or without 100 nM F. Total RNA was treated with DNaseI to remove any genomic DNA contamination (DNaseI, Invitrogen) and its quantity and quality were assessed spectrophotometrically at OD 260/280 and by electrophoresis on 1% agarose gel.
Affymetrix microarray experiments
All experiments were performed using Affymetrix human HgU133A and HgU133B oligonucleotide array set, as described at http://www.affymetrix.com/ products/arrays/specific/hgu133.affyx and complied with Minimum Information About a Microarray Experiment (MIAME) standard. Total RNA was used to prepare biotinylated-target RNA with minor modifications from the manufacturer's recommendations (http://www. affymetrix.com/support/technical/manual/expression_manual.affx). Briefly, 10 mg mRNA (pool of 2 mg total RNA from each cell preparation) were used to generate first-strand cDNA by using a T7-linked oligo(dT) primer (SuperScirpt Double Stranded cDNA Synthesis Kit, Invitrogen). After second-strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP (Enzo Life Sciences, Farmingdale, NY, USA), resulting in approximately 100-fold amplification of RNA. A complete description of procedures is available at http://bioinf.picr.man.ac.uk/mbcf/downloads/GeneChip_Target_Prep_Protocol_CRUK_v_2. pdf. The target cDNA generated from each sample was processed as per manufacturer's recommendation using an Affymetrix GeneChip Instrument System (http:// www.affymetrix.com/support/technical/manual/ expression_manual.affx). Briefly, spike controls were added to 15 mg fragmented cDNA before overnight hybridisation. Arrays were then washed and stained with streptavidin-phycoerythrin, before being scanned on an Affymetrix GeneChip scanner. A complete description of these procedures is available at http://bioinf.picr. man.ac.uk/mbcf/downloads/GeneChip_Hyb_Wash_ Scan_Protocol_v_2_web.pdf. Additionally, quality and amount of starting RNA were confirmed using an agarose gel. After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. 3 0 / 5 0 ratios for glyceraldehyde-3-phosphate dehydrogenase (1) genes with absent call in control and treated cell arrays were deleted; (2) genes with difference call of no change were deleted; (3) genes with absolute signal below 100 were eliminated; (4) genes with signal log ratio (SLR) below 1 for I (increase) or above K1 . 0 for D (decrease) were deleted (arbitrary cut-off point of twofold change) and (5) expressed sequence tags (ESTs) and hypothetical protein entries were not analysed. This filtering procedure generated two datasets: SC preadipocytes treated with F versus control and OM preadipocytes treated with F versus control. Genes were analysed according to their metabolic function, such as glucocorticoid metabolism, transcription factors, genes involved in growth arrest, extracellular matrix (ECM) modulation, adipocyte-specific genes, immune responses, glucose metabolism and metabolic enzymes using NetAffx Analysis Center (www.affymetrix.com).
Reverse transcription
Total RNA (1 mg) in total volume of 20 ml was reverse transcribed using avian myeloblastosis virus reverse transcriptase (AMV-RT) and random hexamers according to manufacturer's protocol (Promega). Fifty nanograms of cDNA (1 ml reverse transcriptase (RT) reaction) were used for real-time PCR to confirm the expression of ten genes.
Real-time PCR
To confirm that the Affymetrix DNA microarray accurately identified the gene expression changes, we carried out quantitative RT-PCR of ten genes with varying degree of change, using the Applied Biosystems 7700 Real-Time PCR System (PE Applied Biosystems, UK). Briefly, PCRs were carried out in 25 ml volumes on 96-well plates, in a reaction buffer containing 2! TaqMan Universal PCR Master Mix. All reactions were singleplexed with the housekeeping gene 18S rRNA on the same plate, provided as a preoptimised control probe (PE Biosystems, Warrington, UK), enabling data to be expressed in relation to an internal reference, to allow for differences in RT efficiency. Measurements were carried out at least three times for each sample. All target gene probes were labelled with FAM, and the housekeeping gene with VIC. Reactions were as follows: 50 8C for 2 min, 95 8C for 10 min; then 44 cycles of 95 8C for 15 s and 60 8C for 1 min. According to the manufacturer's guidelines, data were expressed as Ct values (the cycle number at which logarithmic PCR plots cross a calculated threshold line) and used to determine DCt values (DCtZCt of the target gene minus Ct of the housekeeping gene). To exclude potential bias due to averaging data, which had been transformed through the equation 2
KDDCt to give a fold change in gene expression, all statistics were performed with DCt values. Five sequences of primers and probes used for real-time PCR were designed using PrimerExpress software (Applied Biosystems, UK) and shown in Table 2 . Five other genes; IL-6, IRS2, AGTR1, APOD and FABP4 were validated using commercially available Assay on Demand (Applied Biosystems, Applera, UK). Inter-patient and site differences of gene expressions were tested using individual cDNA preparation. These confirmed the same pattern of change as pooled cDNA used for Affymetrix arrays (data not shown).
Statistical analysis
In comparison analysis where baseline array were the control cells, statistical significance of signal log ratio (SLR; quantitative measure of the relative change in transcript abundance) was calculated. The Wilcoxon's signed rank test was used to compute change P value for each probe set. The P values range in scale from 0 . 0 to 1 . 0 and provide the likelihood of change and direction. P values close to 0 . 0 (!0 . 001) and 1 . 0 (O0 . 998) were used for significant increase and significant decrease respectively (detailed information can be found in GeneChip Expression Analysis, Data Analysis Fundamentals, Affymetrix). For quantitative RT-PCR of the gene validation, statistical software (SPSS for Windows 11.5, SPSS, Inc., UK) was used for statistical analysis. Data are presented as mean values with standard error and P value of !0 . 05 was accepted as statistically significant.
Results
We segregated genes of known function into three groups ( Fig. 1) : (a) SC specific -43 upregulated and 21 downregulated; (b) OM specific -27 upregulated and 10 downregulated and (c) adipose specific -29 upregulated and 9 downregulated in both SC and OM depots. The list of genes with their symbol, GeneBank accession number, description, fold change and function is shown in Table 3 (for increased expression) and Table 4 (for decreased expression).
SC preadipocytes
Genes that were upregulated by cortisol included those associated with negative regulation of cell growth (BTG1, PMP22, CD9, RAI2 and CUGBO2) and apoptosis-related proteins (e.g. CDO1, AMIGO2, CFLAR and CUGBP2) as well as genes involved in cell matrix rearrangements (e.g. CHL1, DPT, ABMLIM, PRELP and KIAA1011; Table 2 ).
Three transcription factors linked to cell growth, C/EBPa, FOS (part of the AP-1 complex) and GFB were upregulated 2 . 0-, 2 . 2-and 2 . 1-fold (respectively).
Additionally, a number of genes linked to lipid metabolism were upregulated -FACL2, LPL and APOB. Significant upregulation of DF (adipsin), FABP4 and AGTR1 was also seen in SC preadipocytes, changes that were absent in OM cells. Expression levels of three of these genes (C/EBPa, FABP4 and AGTR1) as well as C/EBPb and glucocorticoid receptor (GR) were validated by real-time PCR (Figs 2-4).
A number of genes associated to G-protein coupled receptor signalling (EDNRB, GPRC5B, RABGAP1 and TM7SF1) and calcium action (ITPR1 and SPARCL1) were upregulated in depot-specific way ( Table 3) .
Genes that were specifically decreased in SC adipose stromal cells following incubation with cortisol (Table 4) included those positively regulating cell proliferation (VEGF and WARS), oncogenes (ENPP2), anti-apoptotic (OXTR). Interestingly, in SC preadipocytes F-treatment decreased expression of two genes Table 2 Primer and probe sequences (5 associated with Wnt-signalling pathways (FZD7 and SFRP4; 3 . 5-and 3 . 3-fold respectively; Fig. 3 ).
F-treatment significantly decreased IL-6 expression only in SC preadipocytes (2 . 3-fold), however, the absolute signal of IL-6 was much higher in OM preadipocytes. This finding was confirmed and validated by real-time PCR (Fig. 3) . The expression levels of two transcription factors, LDB2 and GATA6, were lowered by cortisol (5 . 0-and 2 . 0-fold respectively). Additionally, SGNE1 (associated Fold induction C/EBPβ with active transport from the ER) and IGFBP5 (IGFsignalling pathway) were downregulated by F (2 . 1-and 2 . 4-fold).
OM preadipocytes
Several genes were specifically upregulated by cortisol but only in OM depots: GAS1, PDGFD and ID1
negatively associated with cell growth (2 . 4-, 2 . 1-and 2 . 6-fold respectively), positively with cell differentiation (DIAPH2, 2 . 0-fold), and ECM proteins (LAMA2, AKAP2, ACKLAM, SPRX and KIAA0992).
A number of metabolic enzymes were upregulated in OM cells only: ALDH1 (2 . 4-fold), AOX1 (3 . 0-fold) and AKR1C1 (2 . 1-fold). Interestingly, among metabolic enzymes involved in glucocorticoid metabolism, HSD11B1 was upregulated in OM preadipocytes (3 . 3-fold), encoding 11b-HSD1 enzyme. This was confirmed using real-time PCR (Fig. 2) Downregulated OM-specific genes included PRAD1 (controlling G1/S transition) and ECM proteins (HAS2 and MMP1). A gene associated with transforming growth factorb signalling (SMURF2) was 2 . 8-fold.
Small inducible cytokine subfamily A, member 11 (CCL11) and leukaemia inhibitory factor involved in immune responses were downregulated 4 . 5-and 2 . 2-fold respectively in OM cells. Interestingly, natriuretic peptide B (NPB), gene involved in electrolyte homeostasis and lipolysis in human adipocytes was decreased 2 . 7-fold by cortisol and was below detection levels in SC cells.
Common adipose-specific genes
Twenty-eight genes were upregulated by cortisol in both SC and OM depots, including those involved in cell cycle regulation and growth (CDKN1C, RGC32 and ADAMTS1), one associated with cell adhesion (NRCAM) and rearrangement of cell matrix (FBN2 and MGP). A number of transcription factors were upregulated in cells from both depots: HXL1, LDO3, TSC22D3, REV3L and ZFP145. Components of insulin-signalling pathway: IRS2, GHR, PDK4 and glucose-regulated chaperone protein (HSPA2) were significantly upregulated by cortisol in SC and OM preadipocytes as apolipoprotein D (ApoD) implicated in lipid metabolism (Table 3 ). IRS2 and GHR expression profiles were validated by real-time PCR (Figs 3 and 4) .
In terms of genes related to the immune response, expression of CD163, CHST2 and CPM all increased in both depots. Plasma glutathione peroxidase 3 precursor (GPX3), catalyses the reduction of hydrogen peroxide, organic hydroperoxide and lipid peroxides, protecting cells against oxidative damage. It was expressed at very high levels in control SC cells and was significantly upregulated in both SC and OM depots by F. Additionally, genes encoding many metabolic enzymes like GLUL (glutamate/nitrogen metabolism), ADH2 (ethanol metabolism) and MAOA (neurotransmitters catabolism) were upregulated in preadipocytes from both depots ( Table 3) .
Most of the genes downregulated by cortisol in both SC and OM preadipocytes were associated with cell cycle control and proliferation/growth processes; e.g. FGF2, TRIB3 and oncogene (C1orf24). As expected, proinflammatory gene such as TNFa induced protein 6 (TNFA1P6) was decreased by cortisol in both depots. Transcription factor DSCR1 was decreased in SC and OM cells (3 . 1-and 2 . 7-fold respectively). Cortisol treatment decreased expression of one component of Wnt-signalling pathway (DACT1) in SC and OM preadipocytes (2 . 6-and 2 . 1-fold respectively), Table 4 . 
Discussion
We have identified several glucocorticoid-regulated genes in human adipose tissue, many of which show site specificity between OM and SC depots that may contribute to the established predilection of glucocorticoids for visceral adiposity. Additionally, these candidates may be informative as we look towards an explanation for the basis of the deleterious distribution of visceral fat.
In terms of the GR itself, earlier studies had reported increased expression in OM adipose tissue when compared with SC fat (Bronnegard et al. 1990 ). Here, we show very similar levels of GR mRNA in preadipocytes of both depots and report that incubation with F for 24 h had no significant effect on GR expression in human SC or OM preadipocytes. By contrast, the study does confirm our earlier reports of increased expression of the 'prereceptor' regulator of GR action, the HSD11B1 gene which encodes the enzyme 11b-hydroxysteroid dehydrogenase type-1 (11b-HSD1) in OM compared with SC preadipocytes and significant upregulation of its expression by F only in OM sites (Bujalska et al. 1997) . The enzyme 11b-HSD2 was absent confirming previous observations (Bujalska et al. 1997) . The explanation for the increased HSD11B1 expression in OM versus SC sites remains unclear. Rodent studies had indicated marked induction of expression by the transcription factors CCAAT enhancer-binding protein a (C/EBPa; Williams et al. 2000) . However, in this human-based study C/EBPa expression was absent in OM preadipocytes and C/ EBPb, whilst being highly expressed in SC and OM preadipocytes, was not regulated by F. It seems unlikely based on these data that C/EBPs play a major role in the site-specific transcriptional regulation of HSD11B1 or GR in human preadipocytes.
Growth arrest/extracellular matrix
Whilst GCs provide a crucial signal for preadipocyte differentiation (Hauner et al. 1987) , the first step defining adipogenesis is cell growth arrest (Ailhaud et al. 1989) . This study looked comprehensively on the effect of GCs on genes associated with cell cycle control. We identified a number of genes such as CDKN1C, which overexpression caused complete cell arrest in G1 phase (Lee et al. 1995) , and RGC32 negatively controlling cell growth (Badea et al. 1998 ) as novel GC-target genes in SC and OM preadipocytes. Furthermore, we found ADAMTS1, gene which disruption in knockout mice caused adipose tissue malformation (Shindo et al. 2000) , being upregulated by GC-target in human preadipocytes together with downregulation of FGF2 providing positive proliferation signal (Kurokawa et al. 1987) . We identified different sets of genes regulating cell growth in depot-specific manner. Only in OM cells, we see increased expression of GAS1 (involved in growth suppression) and decreased of PRAD1 (a G1 marker gene decreased by dexamethasone in airway smooth muscle cells (Fernandes et al. 1999) ), but increased expression of BTG1 in SC cells. Our findings imply site-specific pathway of cell arrest in human preadipocytes.
Interestingly, downregulation of genes, FZD7 and SFRP4 associated with the Wnt-signalling pathway was observed only in SC preadipocytes while upregulation of WISP1, down-stream target of Wnt pathway in hepatocellular carcinoma cells (Cervello et al. 2004) , was seen only in OM cells. Downregulation of Wnt pathway was recently shown to be crucial for the adipogenesis in mouse cell line (3T3L1; Bennett et al. 2002) , however, its role in human preadipocytes still needs to be evaluated.
Preadipocyte growth arrest is accompanied by reorganisation of extracellular matrix (ECM; Gregoire et al. 1991) . We found several novel GC-target genes associated with cell-cell adhesion proteins in human preadipocytes, e.g. FBN2, MGP and NRCAM. However, several ECM GC-target genes were site specific and their role in site-specific adipogenesis remains to be elucidated. For example, in SC cells, CLEC3B (tetranectin) was highly expressed and upregulated by F but below detection levels in OM cells. CHL1 ABLIM, dermatopontin (DPT) and PRELP were GC-target genes of the ECM upregulated only in SC cells. DPT, cartilage matrix component, was recently shown to be upregulated by dexamethasone in chondrogenic differentiation from human bone marrow mesenchymal stem cells (Derfoul et al. 2006) . Conversely, expression of ALCAM, KIAA0992 (identified as risk factor for myocardial infarction; Shiffman et al. 2005) and SRPX was upregulated in OM cells.
Hereby, we demonstrate that GCs induce a sitespecific block on the cell cycle progression together with site-specific differences in ECM remodelling. These would indicate unique pathways of preadipocyte commitment to adipogenesis in these two human adipose tissue depots.
Metabolic enzymes
Human alcohol dehydrogenase 2 (ADH2) exhibits high activity for unsaturated and aromatic alcohols and aldehydes in the metabolism of noradrenaline, retinoids and lipid peroxidation thus plays an important role in detoxification in the liver, reviewed by Higuchi et al. (2004) . This study revealed high ADH2 expression in human preadipocytes (much higher in SC than OM) and positive regulation by GCs in both adipose depots. Dexamethasone has been shown to upregulate ADH2 expression in the HepG2 cell line (Dong et al. 1988) ; I J BUJALSKA and others . Cortisol-target genes in human preadipocytes however, ADH2 expression and its role in the human adipose tissue have not yet been elucidated. On the other hand, aldo-keto reductase family 1, member C1 (AKR1C1), a major enzyme in progesterone metabolism was also highly expressed in SC and OM preadipocytes (again more in SC than OM), but was only upregulated by GCs in OM preadipocytes. AKR1C1 has been shown to be expressed in human SC and OM adipose tissue (Blanchette et al. 2004 ) and positively correlated with visceral obesity. Our findings may provide an explanation for this correlation, since more cortisol is generated in OM tissue due to increased expression of 11b-HSD1.
Adipose-specific genes
In keeping with previous findings (Masuzaki et al. 1995) , leptin expression was undetectable in SC and OM preadipocytes; GCs increased its expression only in SC preadipocytes. It has been shown that C/EBPa upregulates human (Miller et al. 1996) leptin mRNA expression and we confirmed a parallel induction of leptin and C/EBPa by GCs in SC cells. Lipoprotein lipase, an early differentiation marker of adipogenesis has been shown to be expressed at higher levels and upregulated by GCs in SC human female adipose tissue (Fried et al. 1993 ), a pattern that was confirmed in preadipocytes in this study. In rat, insulin is required for the induction of early differentiation genes such as LPL (Gregoire et al. 1991), but we showed that a relatively short exposure to GCs to SC preadipocytes induced LPL expression without the requirement of insulin.
FABP4, product of the aP2 gene, is regulated by dexamethasone in mouse 3T3L1 cells (Cook et al. 1988) as well as in differentiating preadipocytes from rat bone marrow (Atmani et al. 2003) . This study verified FABP4 gene as a glucocorticoid-target gene but only in SC preadipocytes. Upregulation of aP2 gene in response to GCs as well as transcription factors-binding sites for C/ EBP and c-fos (forming AP-1 complex) in the promoter region of mouse aP2 gene was shown previously (Ross et al. 1990 ). Our findings, demonstrating increased expression of these two transcription factors together with FABP4 expression in SC preadipocytes, might reflect different sensitivity of human SC and OM preadipocytes to adipogenic effect of GCs.
ApoD is involved in cellular transport of small hydrophobic ligands, such as progesterone, cholesterol, pregnenolone, bilirubin and arachidonic acid but its exact role is still not known. ApoD was expressed at similar levels in SC and OM preadipocytes but these fat compartments responded differently to GC (upregulation SCOOM). On the other hand, ApoB, component for VLDL associated with type-2 diabetes and insulin resistance reviewed by Ginsberg et al. (2005) and increased risk of coronary heart disease (Despres 1998), was positively regulated only in SC cells. Although our finding provides evidence for glucocorticoid regulation of ApoB in human SC preadipocyte, its significance needs to be evaluated.
Natriuretic peptides have been shown to have a potent lipolytic effect in human adipocytes (Sengenes et al. 2000) . Moreover, significantly reduced levels of NPB have been found in obese patients with heart failure (Mehra et al. 2004) . Our finding shows NPB expression in OM preadipocytes as well as GC-target gene (but absent in SC) could provide a novel mechanism explaining the relationship between glucocorticoids, central obesity and heart failure. Moreover, increased expression of ADM has been positively correlated with cardiovascular disease and hypertension reviewed in Nikitenko et al. (2002) . Here, we found ADM as a novel GC-target gene only in OM preadipocytes; its angiogenic and anti-lipolytic effects (Harmancey et al. 2005) might be an important factor explaining depot specificity of GC action in human adipose tissue.
Genes involved in glucose metabolism/insulin signalling
Many genes were similarly expressed and regulated by GCs in preadipocytes from both depots. Among them was the growth hormone receptor (GHR). GH has an anti-insulin activity (Roupas et al. 1991) and the upregulation of its receptor by GCs may be one mechanism underpinning GC-induced insulin resistance.
Insulin receptor substrate (IRS) plays a crucial role in adipogenesis; IRS2 (K/K) embryonic mouse fibroblasts retain only 15% of their ability to differentiate to adipocytes (Miki et al. 2001) . IRS2 knockout mice develop progressive deterioration in glucose homeostasis through impaired insulin signalling in the liver and skeletal muscle leading to type-2 diabetes (Withers et al. 1998) . IRS2 expression was higher in OM than SC preadipocytes, but was induced to a similar extent by GCs in both depots.
PDK4, an enzyme involved in glucose metabolism and fatty acid synthesis is known to be expressed in skeletal muscle and adipose tissue (Rowles et al. 1996) . Decreased PDK4 in muscle has been associated with increased insulin sensitivity (Rosa et al. 2003) and increased expression with insulin resistance, diabetes and hyperthyroidism reviewed by Sugden (2003) . The relationship between PDK4 and glucocorticoids has been studied in HepG2 cells but not in human adipose tissue. Elevation of PDK4 expression in human preadipocytes might be an additional factor in GC-induced insulin resistance.
Anti-inflammatory
In general, primary preadipocyte cultures isolated from human adipose tissue represent heterogeneous cell populations, some of which can be a part of the immune system (Kershaw & Flier 2004) . In this study, we observed GC effects on genes associated with immune responses, such as IL-6, TNFAIP6 and CD163. Activation of anti-inflammatory protein, TNFAIP6 (TNFa-stimulated gene 6) gene by NF/IL-6 was previously demonstrated (Klampfer et al. 1995) . The simultaneous GC-induced downregulation of the TNFAIP6 and IL-6 in human preadipocytes might reflect interaction between these two genes in adipose tissue inflammation. GPX3, plasma glutathione peroxidase 3 precursor, catalyses the reduction of hydrogen peroxide, organic hydroperoxide and lipid peroxides, thus protecting cells against oxidative damage. GPX3 was reported to be present in human adipose tissue (Maeda et al. 1997) , and here we identified GPX3 expression as being one of the most highly expressed genes in preadipocyte compartment of human adipose tissue as well as a novel GC-target gene.
Recently, adipose tissue has been identified as a major production site of serum amyloid A (ASSA; Sjoholm et al. 2005) , a known risk factor for coronary artery disease (Johnson et al. 2004) . In this study, we have shown that ASSA is a GC-target gene in OM preadipocytes. Together, these findings contribute to the role of OM tissue as a potential link between an inflammatory response and coronary disease.
Transcription factors
Several transcription factors are known to be key regulators of the adipogenic processes, reviewed by MacDougald & Mandrup (2002) . In this study, we identified distinctively different as well as common sets of transcription factors involved in early glucocorticoidinduced adipogenesis in human SC and OM adipose tissues. Downregulation of Wnt-signalling pathway during adipogenesis has been shown in 3T3 cells (Bennett et al. 2002) . Here, we demonstrate that the downregulation of Wnt-signalling pathway, as well as the induction of C/EBPa occurs only in SC preadipocytes. Different transcription factors, FOXO1A (upregulated in OM cells) and FOS (upregulated in SC cells), were the depot-specific early GC-targets genes. FOXO1 is induced in early stages of adipocyte differentiation (Nakae et al. 2003) ; our finding confirmed this but only in OM depots. Recently, involvement of two members of the zinc finger proteins family of the transcription factors, KLF2 and KLF15 has been reported in adipogenesis (Gray et al. 2002 , Banerjee et al. 2003 . Our study identified another member of this family, zinc finger protein 145 (ZFP145) as a novel, common, GC-target in human preadipocytes. Moreover, the pattern of induction from undetectable levels suggests its important role in GCs-induced adipogenesis; however, the functional role of ZFP145 in adipose tissue needs to be further evaluated.
Summary
In summary, we have identified novel tissue-specific GC-target genes in SC and OM abdominal preadipocytes. The profile and intensity of fold changes in the expression of ten genes was confirmed by quantitative real-time PCR, indicating that the data obtained from our DNA array analysis are robust. The different sensitivity to GCs of SC and OM preadipocytes might explain heterogeneity as well as metabolic differences between these adipose depots in man.
